Mark C. Mc Kenna New Amsterdam Pharma CO N.V. (NAMS) insider trading activity

NAMS Quotes by TradingView
Shares Held (Direct Ownership) 10.4K
48.85% 3M change
48.85% 12M change
Total Value Held N/A

Mark C. McKenna Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 07 2026
BUY
Grant, award, or other acquisition
-
3,400 Added 24.71%
10,360 Ordinary Shares
Jan 07 2025
BUY
Grant, award, or other acquisition
-
6,960 Added 50.0%
6,960 Ordinary Shares

Also insider at

RXDX
Prometheus Biosciences, Inc. Healthcare
Chairman, President and CEO
APGE
Apogee Therapeutics, Inc.
Director
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
Director
HLXB
Helix Acquisition Corp. II
MCM

Mark C. Mc Kenna

San Diego, CA

Track Institutional and Insider Activities on NAMS

Follow NewAmsterdam Pharma Co N.V. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAMS shares.

Notify only if

Insider Trading

Get notified when an New Amsterdam Pharma CO N.V. insider buys or sells NAMS shares.

Notify only if

News

Receive news related to NewAmsterdam Pharma Co N.V.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NAMS